19:34 , May 17, 2018 |  BC Innovations  |  Finance

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized...
18:27 , Apr 5, 2018 |  BC Innovations  |  Emerging Company Profile

Stoking protein production

Stoke Therapeutics Inc. is developing ASOs to boost normal protein expression as disease-modifying therapies for autosomal-dominant diseases that are not amenable to recombinant protein or gene therapies. Co-founders Adrian Krainer and Isabel Aznarez previously discovered cell...
00:41 , Dec 19, 2017 |  BC Extra  |  Preclinical News

New stable macrocycles for peptide therapeutics

In a paper published in Science, University of Washington researchers used computational design to identify over 200 peptide macrocycle structures that form stable scaffolds on which therapeutics can be constructed. The team, led by David...
22:20 , Nov 20, 2017 |  BC Extra  |  Company News

Management tracks: Shire, Aveo

Shire plc (LSE:SHP; NASDAQ:SHPG) named Thomas Dittrich CFO, effective early 2018. He is CFO at machinery manufacturing firm Sulzer Ltd. (SIX:SUN). In August, Shire said Jeff Poulton will depart as CFO at year end (see...
19:56 , Sep 22, 2017 |  BC Week In Review  |  Financial News

Lightstone closes $250M fund

On Sept. 20, Lightstone Ventures (Menlo Park, Calif.) closed Lightstone Ventures II at $250 million. Lightstone said the fund will invest $15-$20 million in each of about 15 early stage biotech and medical device companies....
20:06 , Sep 20, 2017 |  BC Extra  |  Financial News

Lightstone closes $250M fund

Lightstone Ventures closed Lightstone Ventures II at $250 million. Lightstone said the fund will invest $15-$20 million in each of about 15 early stage biotech and medical device companies. The fund has invested in one...
18:35 , Jul 6, 2017 |  BC Week In Review  |  Financial News

Novo Seeds invests €2.7M in Antag

On June 28, metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark). Antag is developing...
20:42 , Jun 28, 2017 |  BC Extra  |  Financial News

Novo Seeds invests €2.7M in Antag

Metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it has received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark). Antag is developing peptide therapeutics...
22:01 , Jun 21, 2017 |  BC Innovations  |  Distillery Techniques

Drug delivery

TECHNOLOGY: Polymers PEG-based hydrogel microspheres that release peptide drugs continuously over several weeks could help treat Type II diabetes and other chronic diseases with once-monthly dosing. The microspheres are linked to peptide therapeutics via a carbamate...
00:25 , Jun 21, 2017 |  BC Extra  |  Company News

Management tracks

Biogen Inc. (NASDAQ:BIIB) named Ginger Gregory EVP and chief human resources officer, effective July 17. She was chief human resources officer at Shire plc (LSE:SHP; NASDAQ:SHPG). Neurodegenerative, inflammation and cancer company Active Biotech AB (SSE:ACTI) promoted...